Abstract
Screening should decrease disease-related mortality by detecting cancer before symptoms prompt evaluation. Several characteristics of bladder cancer make screening an attractive option. Nevertheless, premature adoption of a screening program has considerable negative consequences. This article reviews the current literature regarding screening for bladder cancer and emphasizes the need for prospective, clinical trials before considering practice modification.
Original language | English (US) |
---|---|
Pages (from-to) | 339-341 |
Number of pages | 3 |
Journal | Current urology reports |
Volume | 9 |
Issue number | 5 |
DOIs |
|
State | Published - Sep 2008 |
ASJC Scopus subject areas
- Urology